Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome

Scandinavian Journal of Rheumatology

Volumn 40, Issue 5, 2011, Pages 387-390

  Porola, P ^a,b   Straub, R H ^c   Virkki, L M ^b   Konttinen, Y T ^a,b,d,e,f   Nordstrom D C ^a,b  

^a HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^e University of Tampere   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANE DIOL GLUCURONIDE; ANDROSTENEDIONE; DIHYDROTACHYSTEROL; PLACEBO; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; PRIORITY JOURNAL; SALIVA LEVEL; SALIVARY GLAND; SALIVATION; SJOEGREN SYNDROME; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

ADULT; AGED; ANDROGENS; DEHYDROEPIANDROSTERONE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME; TREATMENT FAILURE;

EID: 80053415160     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.580000     Document Type: Article

References (15)

1. Vitali CS, Bombardierdi R, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
2. Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroepiandrosterone sulphate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001;28:1259-65. (Pubitemid 32510496)
3. Laine M, Porola P, Udby L, Kjeldsen L, Cowland JB, Borregaard N, et al. Low salivary DHEA and androgen-regulated CRISP-3 in Sjögren's syndrome. Arthritis Rheum 2007;56:2575-84.
4. Porola P, Virkki L, Przybyla BD, Laine M, Patterson TA, Pihakari A, et al. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome. J Rheumatol 2008;35:2229-35.
5. Spaan M, Porola P, Laine M, Rozman B, Azuma M, Konttinen YT. Healthy human salivary glands contain a DHEA-S processing intracrine machinery, which is deranged in primary Sjögren's syndrome. J Cell Mol Med 2009;13:1261-70.
6. Forsblad d'Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C. Low serum levels of sex-steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab 2009;94:2044-51.
7. Virkki LM, Porola P, Forsblad-d'Elia H, Valtysdottir S, Solovieva SA, Konttinen YT. Dehydroepiandrosterone (DHEA) substitution treatment in severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome. Arthritis Care Res (Hoboken) 2010;62:118-24.
8. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005;122:751-62. (Pubitemid 41242639)
9. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7. (Pubitemid 24181005)
10. van Niekerk JK, Huppert FA, Herbert J. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 2001;26:591-612. (Pubitemid 32524189)
11. Alhaj HA, Massey AE, McAllister-Williams RH. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl) 2006;188:541-51. (Pubitemid 46758956)
12. Swinkels LM, Meulenberg PM, Ross HA, Benraad TJ. Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel. Ann Clin Biochem 1988;25:354-9.
13. Granger DA, Schwartz EB, Booth A, Curran M, Zakaria D. Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults. Psychoneuroendocrinology 1999;24:567-79. (Pubitemid 29268436)
14. Ahn RS, Lee YJ, Choi JY, Kwon HB, Chun SI. Salivary cortisol and DHEA levels in the Korean population: age-related differences, diurnal rhythm, and correlations with serum levels. Yonsei Med J 2007;30:48:379-88.
15. Labrie F, Luu-The V, Belanger A, Lin SX, Simard J, Pelletier G, et al.Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169-96. (Pubitemid 41685178)